bioRxiv/medRxiv TRiP Review Activity

428 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 7: Articles 61-70  | Next

Loss-of-function cancer-associated mutations in the EIF4G2 non-canonical translation initiation factor
Meril, S., Bahlsen, M., Eisenstein, M., Savidor, A., Levin, Y., Bialik, S., Pietrokovski, S., Kimchi, A.
10.1101/2023.08.22.554280 — Posted: 2023-08-25 — Discussion: 2025-05-20  EMBO Press
Mitochondrial Signatures Shape Phenotype Switching and Apoptosis in Response to PLK1 and RSK Inhibitors in Melanoma
Lavallee, E., Roulet-Matton, M., Giang, V., Cardona Hurtado, R., Chaput, D., Gravel, S.-P.
10.1101/2024.06.14.599035 — Posted: 2024-06-17 — Discussion: 2025-05-20  EMBO Press
Shared requirement for MYC upstream super-enhancer in tissue regeneration and cancer
Sur, I. K., Zhao, W., Zhang, J., Kling Pilstrom, M., Rozell, B., Webb, A., Cheng, H., Ristimaki, A., Katajisto, P., Enge, M., Rannikmae, H., de la Roche, M. A., Taipale, J.
10.1101/2022.11.04.515076 — Posted: 2022-11-05 — Discussion: 2025-05-20  EMBO Press
Transcription Factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress
Van Den Berg, C. L., Soleimani, M., Goyal, R., Somma, A., Kaoud, T., Dalby, K. N., Kowalski, J., Eckhardt, S. G.
10.1101/2023.05.30.542913 — Posted: 2023-05-31 — Discussion: 2025-05-20  EMBO Press
Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells
Chen, Y.-C., Takada, M., Nagornyuk, A., Muhan, W., Yamada, H., Nagashima, T., Ohtsuka, M., DeLuca, J. G., Markus, S. M., Takaku, M., Suzuki, A.
10.1101/2024.11.04.621816 — Posted: 2024-11-07 — Discussion: 2025-05-13  eLife
Reduction in ETFDH expression optimizes cancer cell bioenergetics
Papadopoli, D., Palia, R., Jovanovic, P., Tabaries, S., Ciccolini, E., Sabourin, V., Igelmann, S., McLaughlan, S., Zhan, L., Kim, H., Chekkal, N., Szkop, K. J., Bertomeu, T., Zeng, J., Vassalakis, J., Afzali, F., Mzoughi, S., Guccione, E., Tyers, M., Avizonis, D., Larsson, O., Postovit, L.-M., Djuranovic, S., Ursini-Siegel, J., Siegel, P. M., Pollak, M., Topisirovic, I.
10.1101/2024.10.25.620155 — Posted: 2024-10-25 — Discussion: 2025-05-09  eLife
Integrated Analysis of Single-Cell and Bulk RNA-Seq Data reveals that Ferroptosis-Related Genes Mediated the Tumor Microenvironment predicts Prognosis, and guides Drug Selection in Triple-Negative Breast Cancer
Gong, X., Gu, L., Yang, D., He, Y., Li, Q., Qin, H., Wang, Y.
10.1101/2024.07.04.602021 — Posted: 2024-07-06 — Discussion: 2025-05-09  eLife
Repression of the Wnt pathway effector TCF7L2 reverses lethal cachexia in mice with intestinal cancers
Leong, M. L., Ruedl, C., Karjalainen, K.
10.1101/2024.11.22.624913 — Posted: 2024-11-25 — Discussion: 2025-05-07  eLife
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer
Li, S., Song, K., Sun, H., Tao, Y., Huang, A., Bhatia, V., Hanratty, B., Patel, R. A., Long, H. W., Morrissey, C., Haffner, M. C., Nelson, P. S., Graeber, T. G., Lee, J. K.
10.1101/2025.02.12.637904 — Posted: 2025-02-17 — Discussion: 2025-04-30  eLife
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Nakagawa, R., Beardsley, A., Durney, S., Hayward, M.-K., Subramanyam, V., Meyer, N. P., Wismer, H., Goodarzi, H., Weaver, V. M., Van de Mark, D., Goga, A.
10.1101/2024.09.26.615226 — Posted: 2024-09-28 — Discussion: 2025-04-25  eLife

Evaluation Sources